Richard Kaner
Geriatric Medicine · Bellevue, WANPI 1437226750
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 231 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 10.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,452 and has fallen 66.2% since, to $491 in 2024. Among geriatric medicine clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 231 payments — averaging $20.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$526
- Boehringer Ingelheim$443
- AstraZeneca$423
- Pfizer$410
- Johnson & Johnson$386
- AbbVie$370
- plus $2K from 30 others
What the payments were for
- Food & beverage$4,821100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 22 | $526 |
| Boehringer Ingelheim | 19 | $443 |
| AstraZeneca | 17 | $423 |
| Pfizer | 19 | $410 |
| Johnson & Johnson(2 entities) | 17 | $386 |
| AbbVie(2 entities) | 19 | $370 |
| Novo Nordisk | 19 | $335 |
| Lilly USA, LLC | 12 | $233 |
| E.r. Squibb & Sons, L.L.C. | 6 | $193 |
| Novartis | 7 | $135 |
| Alfasigma USA, Inc. | 6 | $133 |
| Merck | 8 | $127 |
| Radius Health, Inc. | 5 | $95 |
| Esperion Therapeutics, Inc. | 5 | $94 |
| Astellas Pharma US Inc | 6 | $93 |
| Impulse Dynamics (USA) Inc. | 3 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $72 |
| Kowa Pharmaceuticals America, Inc. | 4 | $69 |
| Regeneron Healthcare Solutions, Inc. | 3 | $66 |
| Teva Pharmaceuticals USA, Inc. | 3 | $65 |
| Lundbeck LLC | 2 | $56 |
| Abbott | 3 | $52 |
| Dexcom, Inc. | 2 | $45 |
| Idorsia Pharmaceuticals US Inc | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $34 |
| Electromed, Inc. | 1 | $28 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| Amneal Pharmaceuticals LLC | 1 | $23 |
| Sanofi Pasteur Inc. | 1 | $22 |
| Echosens North America, Inc. | 1 | $22 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
| GSK | 1 | $20 |
| Currax Pharmaceuticals LLC | 1 | $18 |
| Bayer | 1 | $17 |
| Avion Pharmaceuticals | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,821 in reported general payments places this provider in the 95th percentile of 77 geriatric medicine providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 85 | $96,654 |
| FarxigaDapagliflozin Propanediol | 55 | $51,338 |
| RybelsusSemaglutide | 16 | $25,602 |
| OzempicSemaglutide | 14 | $13,045 |
| JardianceEmpagliflozin | 14 | $9,768 |
| Praluent PenAlirocumab | 13 | $6,462 |
| SynthroidLevothyroxine Sodium | 28 | $3,424 |
| Ezetimibe | 99 | $2,743 |
| Rosuvastatin Calcium | 151 | $2,510 |
| Atorvastatin Calcium | 143 | $1,634 |
| Losartan Potassium | 105 | $1,556 |
| Amlodipine Besylate | 118 | $1,410 |
| Levothyroxine Sodium | 88 | $1,034 |
| Estradiol | 13 | $981 |
| Tamsulosin Hcl | 48 | $882 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $410 | $96,65485 claims |
| AstraZenecaFarxiga | $423 | $51,33855 claims |
| Novo NordiskRybelsus, Ozempic | $335 | $38,64730 claims |
| Boehringer IngelheimJardiance | $443 | $9,76814 claims |
| AbbVieSynthroid | $370 | $3,42428 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $23 | $1,03488 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 77 geriatric medicine providers in Washington.
Other geriatric medicine in Bellevue
- Lacee MeyerBellevue$3K
- Daniel RaskindBellevue$983
- Benjamin PintoBellevue$890
- Priyanka DuggalBellevue$388
- Genevie MoranBellevue$0
- John Dugawla Conner$34K
- Angela HansonSeattle$12K
- Neeti MittalMercer Island$7K
- Sabine von Preyss-FriedmanSeattle$3K
- Suzanne StaudingerBenton City$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.